"QOL Medical to Acquire Evoke Pharma for $11 Per Share in Cash"

Latham & Watkins LLP represented Evoke Pharma, Inc. in the transaction, while QOL Medical, LLC was the acquiring party. The transaction involved QOL Medical acquiring Evoke Pharma for US$11 per share in cash at closing, conducted via a tender offer. The deal was unanimously approved by the Boards of Directors of both companies. The Latham & Watkins LLP team assisting Evoke included corporate partners Daniel Rees (Orange County) and Matthew Bush (San Diego), with associates Shannon Cheng, Amy Lutfi, Ashley Campfield, and Joanna Yam, and assistance from Chloe Wallace. The Capital Markets team included counsel Anthony Gostanian and associate Shelby Harrison. Advice on executive compensation, employment, and benefits matters was provided by San Diego partner Holly Bauer and associate Julie Voorhes. Regulatory and healthcare compliance matters were handled by Bay Area partner Betty Pang and Washington, D.C. counsel Chad Jennings. Tax matters were addressed by Los Angeles partner Pardis Zomorodi and Houston partner Christine Mainguy, with associate Tessa Young. Intellectual property matters were managed by San Diego partner Steven Chinowsky, counsels Darryl Steensma and Robert Yeh, and associate Kristina Funahashi. Data privacy and cybersecurity matters were overseen by Bay Area partner Heather Deixler and associate Kathryn Parsons-Reponte. Trademark advice was provided by New York counsel Lindsey Utrata.

"QOL Medical to Acquire Evoke Pharma for $11 Per Share in Cash"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads